Question 19

Methylphenidate is available in a transdermal system.

Methylphenidate can be delivered through a transdermal system, allowing for continuous medication release over time, which is beneficial for managing ADHD symptoms.

A) Atomoxetine

Atomoxetine is an oral medication used for the treatment of ADHD and is not available in a transdermal system. Its mechanism of action differs from that of medications like methylphenidate, as it primarily works as a selective norepinephrine reuptake inhibitor.

B) Methylphenidate

Methylphenidate is indeed available in a transdermal patch form, known as Daytrana. This delivery system provides a steady release of the medication throughout the day, which can enhance adherence and effectiveness for patients with ADHD.

C) Modafinil

Modafinil is primarily used to treat narcolepsy and other sleep disorders and is not indicated for ADHD. It is available in oral form only and does not have a transdermal formulation.

D) Fentanyl

Fentanyl is a powerful opioid analgesic that is available in a transdermal patch form, but it is not used to treat ADHD. Its use is primarily for severe pain management, making it irrelevant in the context of ADHD treatment.

Conclusion

Methylphenidate stands out as the only medication listed that is available in a transdermal system for ADHD treatment, providing a unique option for continuous delivery. Other options, such as atomoxetine, modafinil, and fentanyl, do not fit the criteria, either due to their formulation or the conditions they treat. Thus, methylphenidate is the definitive correct choice.